Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03868410 · ClinicalTrials.gov registry record · Early Phase 1
A Novel Approach for Brain Stimulation in Severe Stroke
A Early Phase 1 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 16
- Enrollment target
NCT03868410 is a Early Phase 1 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 16 participants.
The verdict
NCT03868410, a Early Phase 1 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The long-term goal of this project is to develop upper limb rehabilitation interventions that can be utilized for stroke survivors, specifically survivors with more severe limitations in use of their affected upper limb. This study will utilize a novel method of non-invasive brain stimulation in conjunction with upper limb training given for 12 visits over a period of 6 weeks. The study will include the following site visits: * Eligibility Screening and Informed Consent Visit * An MRI visit * Two testing visits in which motor function of the upper limb and neurophysiology will be measured * 12 intervention visits during which patients will receive upper limb training in conjunction with non-invasive brain stimulation * Repeat testing of motor function of the upper limb and neurophysiology * Repeat MRI testing * A follow-up visit completed 3 months after the completion of interventions
Interventions
- DEVICE New Repetitive Magnetic Stimulation (rTMS) Approach
- DEVICE Conventional Repetitive Magnetic Stimulation (rTMS) Approach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2023-07-13 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03868410
The ClinicalTrials.gov registry entry for NCT03868410 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which New Repetitive Magnetic Stimulation (rTMS) Approach is the first listed.
NCT03868410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03868410 about?
NCT03868410 is a clinical study titled "A Novel Approach for Brain Stimulation in Severe Stroke". The long-term goal of this project is to develop upper limb rehabilitation interventions that can be utilized for stroke survivors, specifically survivors with more severe limitations in use of their affected upper limb. This study will utilize a novel method of non-invasive brain stimulation in co...
What is the current status of trial NCT03868410?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 16 participants. The study started on 2019-04-01. Estimated completion is 2023-07-13.
What interventions are being tested in trial NCT03868410?
The interventions under investigation include: New Repetitive Magnetic Stimulation (rTMS) Approach (DEVICE), Conventional Repetitive Magnetic Stimulation (rTMS) Approach (DEVICE).
Who is sponsoring clinical trial NCT03868410?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.